#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary hyperoxaluria Congenital megacolon Myotonia Squamous cell carcinoma of the hypopharynx Microscopic polyangiitis Granulomatosis with polyangiitis Biliary cancer metastatic Mitochondrial myopathy Cutaneous T-cell lymphoma Sjogren's syndrome Philadelphia positive chronic myeloid leukaemia Splenic marginal zone lymphoma Idiopathic inflammatory myopathy Myeloid leukaemia Rectal cancer More trials…

    Learn about Rare Diseases

    Pleural mesothelioma malignant – Treatment Hereditary angioedema with C1 esterase inhibitor deficiency Niemann-Pick disease – Basic Information Hairy cell leukaemia – Trials in Disease Carcinoid syndrome – Treatment Alexander disease – Trials in Disease Stevens-Johnson syndrome – Treatment Mast cell activation syndrome – Diagnostics Anaplastic thyroid cancer – Trials in Disease Immunodeficiency congenital – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Farletuzumab Ecteribulin MB-001 Ngi226 Fludeoxyglucose (18F) Calcium Folinate Pentahydrate Nnc0194-0499 Botensilimab Baclofen Blomia Tropicalis Sodium Ng004 Tolebrutinib Thiamine Hydrochloride Cipaglucosidase Alfa Treosulfan Capsaicin Anidulafungin Bms-986315 Cerebrolysin Concentrate Dl-Alpha Tocopherol Acetate More therapies…

    Learn about Your Condition

    Erosive oesophagitis Renal cancer recurrent Hepatoblastoma Cartilage injury Drug dependence Infertility female Biopsy heart Dent's disease Haemodialysis Otitis media Vascular malformation Myofascial pain syndrome Pneumonia chlamydial Graft versus host disease Thrombolysis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. CHRU de Tours- Hôpital Trousseau

CHRU de Tours- Hôpital Trousseau

Avenue De La Republique, Chambray Les Tours, 37170, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Prednisone
    • Secukinumab
    Belgium Czechia Denmark Finland France Germany +9
  • Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    • Milvexian
    Austria Belgium Bulgaria Croatia Czechia Denmark +14
  • Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Secukinumab
    Bulgaria Czechia Denmark France Portugal Slovakia
  • Comparison of drug combinations containing irinotecan, oxaliplatin, fluorouracil and folinic acid for treatment of high-risk stage III colon cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Irinotecan
    France Italy
  • Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Apixaban
    • Asundexian
    Austria Belgium Bulgaria Czechia Denmark Estonia +16
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!